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Objective*/Among detractors of elective neck (N0) treatments, most suggest that lymphadenectomy removes a barrier to the
spread of disease with deleterious immunologic consequences. To test this hypothesis we performed a retrospective
comparison of the survival results of N0 laryngeal cancer patients who received unnecessary elective neck treatments (N0/)
and those of N0 patients subjected to close and regular follow-up.
Material and Methods*/A retrospective chart review of 749 N0 laryngeal cancer patients treated at the Institute of
Otolaryngology*/Head and Neck Surgery, University of Florence between January 1980 and January 1993 was performed.
Of these, 245 (33%) received elective neck dissection (ED), while the remaining 504 (67%) N0 patients were subjected to close
and regular follow-up (wait-and-see policy; WS).
Results*/Of the 245 ED patients, 43 (17.5%) showed an occult neck disease, while of the 504 WS subjects, 83 (17%)
developed neck metastases during follow-up. Moreover, 15 ED patients subsequently experienced a contralateral occult
failure despite a unilateral negative neck specimen (N0/). Thus, ultimately 187 ED (164 of whom were treated unilaterally
and 23 bilaterally) and 421 WS patients were used for survival analysis. No differences in terms of postoperative
complications, local or distant failure or disease-free or overall actuarial survival were found between the two groups
analyzed.
Conclusions*/These data indicate that unilateral or bilateral removal of cervical lymphatics in the absence of histologically
proven lymph node metastases does not negatively affect the prognosis of N0 laryngeal cancer patients who were overtreated
to the neck. Key words: laryngeal cancer, N0, neck surgery, prognosis, squamous cell carcinoma.
INTRODUCTION
In patients with squamous cell carcinoma of the
larynx, and particularly of the supraglottis, manage-
ment of the regional lymphatics is a crucial compo-
nent of the overall treatment plan. If metastases to the
cervical lymph nodes are clinically evident at diag-
nosis, treatment of the neck is mandatory. The
situation is more controversial when the laryngeal
cancer patient does not manifest clinical signs of neck
disease (N0 patient). In this situation the physician
must decide whether to perform elective treatment on
the cervical lymph nodes or simply to wait for
metastases to develop and then treat the patient
when and if they occur. This issue, however, has yet
to be resolved (1, 2).
At most institutions, a frequency of occult metas-
tases exceeding 15/20% is considered to sufficient to
justify elective neck therapy (2/6). Common argu-
ments supporting this policy include the inevitable
progression of occult nodal disease into clinically
evident metastases requiring delayed therapeutic treat-
ment of high-stage neck disease (7), the occurrence of
inoperable neck disease in some N0 cases despite close
and regular follow-up and, finally, the increased risk of
the development of distant metastases in patients with
untreated occult neck metastasis (2/8). On the other
hand, elective surgical treatment of the clinically
negative neck in each instance of primary larynx
carcinoma, obviously excluding T1 glottic tumors,
could produce unnecessary morbidity, with higher
medical costs and a longer hospital stay in a majority
of patients (70/80%) who are not likely to have
cervical node metastases (9, 10). Furthermore, the
appropriate use of ultrasound-guided fine-needle as-
piration cytology seems to be more effective in
controlling the great majority of neck disease in
head and neck squamous cell cancer patients (11/
13). Moreover, it has been postulated that elective
neck dissection removes a barrier to the spread of
disease and also has a deleterious effect on the
immune system because it eliminates sites of immune
activation (2, 14). In agreement with a prognostic role
of regional lymph node activation, improved survival
has been linked with an active immunologic response
detected in regional cervical lymph nodes from head
and neck cancer patients in several studies (15/20).
This hypothesis further supports the theory of im-
munological surveillance with respect to cancer (21/
23). In this regard, elective neck dissection could at
least in theory weaken the host’s mechanism(s) of
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recognition and elimination of neoplastic emboli from
the primary tumor site and be responsible for regional
and distant metastases (14, 15).
The aim of this study was to evaluate retrospectively
the prognostic impact of unnecessary elective lympha-
denectomy in N0/ laryngeal cancer patients. This
hypothesis prompted us to compare the disease-free
interval, actuarial and crude survival of two patient
populations, both characterized by clinically negative
neck at the initial diagnosis, the first of which received
elective neck treatment and the second of which was
subjected to close and regular follow-up.
MATERIAL AND METHODS
Our study population was selected from a database
containing 749 previously untreated patients [723 men
(96.5%), 26 women (3.5%); age range 47/79 years;
median age 64.5 years] with laryngeal squamous cell
carcinoma and a clinically negative neck (N0) who
underwent surgical treatment at the Institute of
Otolaryngology*/Head and Neck Surgery, University
of Florence between January 1980 and January 1993.
Of these 749 patients, 245 (33%) received elective neck
dissection (ED) as part of their primary treatment,
while the remaining 504 (67%) were subjected to close
and regular follow-up, according to a wait-and-see
policy (WS) (Fig. 1). The site and T-stage of the
tumors according to the 1997 International Union
Against Cancer guidelines are shown in Table I.
It has been suggested that elective neck dissection
has a potentially detrimental prognostic significance in
patients who do not have histologically positive occult
lymph node disease (N0/), in comparison with N0
patients who are not electively treated to the neck
(wait-and-see policy). Therefore, we attempted to
analyze the survival rates in these two groups,
obviously excluding from both arms those laryngeal
cancer patients who were experiencing occult neck
disease, either histologically confirmed after an elec-
tive lymphadenectomy in the ED group or which
occurred during follow-up in the absence of a local
failure in the WS group. Therefore, the patients
recruited were divided into two groups: (i) those with
cancer of the larynx who had undergone an elective
neck dissection with histologically negative neck
(N0/; 202 ED patients); and (ii) those who had not
undergone elective neck treatments without the clin-
ical appearance of neck disease for at least 5 years of
their follow-up (421 WS patients). None of these
patients were submitted to adjuvant radiotherapy of
the neck as empirical radiotherapy performed on a
clinically negative neck would not have allowed
evaluation of the development of occult cervical
metastases, and thus would have led to the exclusion
of these patients from the study group.
The criteria for selecting N0 laryngeal cancer
patients for elective neck surgery were mostly sub-
jective; however, an elective treatment was reserved for
patients with advanced lesions (T3/4), supraglottic
lesions, well-lateralized lesions involving peripheric
laryngeal structures (which are usually at higher risk
of occult node metastases), low-grade lesions and a
short, fat neck leading to a difficult clinical examina-
tion. Conversely, a wait-and-see policy was employed
in elderly patients or when the general conditions were
poor, implicating high-risk surgical procedures.
In the ED group, 179 patients were treated with a
unilateral elective lymphadenectomy and 23 with
bilateral elective neck surgery. A functional neck
dissection was the elective neck procedure performed
unilaterally and bilaterally in all ED patients. Func-
tional neck dissection was performed according to the
technique proposed by Sua`rez (24), with preservation
of the spinal accessory nerve, sternocleidomastoid
muscle and internal jugular vein (all these structures
Table I. Tumor stage and site distribution for the ED and WS groups. The values shown represent numbers of
patients, with percentages in parentheses
ED group WS group Total
T-stage
T1 17 (6.94) 169 (33.53) 186 (24.8)
T2 70 (28.56) 145 (28.80) 215 (28.7)
T3 119 (48.58) 178 (35.32) 297 (39.7)
T4 39 (15.92) 12 (2.35) 51 (6.8)
Total 245 (100) 504 (100) 749 (100)
Site
Supraglottic 120 (48.98) 252 (50.00) 372 (49.67)
Glottic 107 (43.67) 238 (47.22) 345 (46.06)
Subglottic 18 (7.35) 14 (2.78) 32 (4.27)
Total 245 (100) 504 (100) 749 (100)
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are routinely removed by conventional radical neck
procedures), but with removal of level II/V cervical
lymph nodes.
Follow-up was at least 5 years or until death. A
comparison was made between the two subsets of
patients in terms of disease-free and overall survival.
Considering the cause of death in this population,
with particular reference to distant metastases and
subsequent primary cancers, the criteria we used in
particular for distinguishing lung metastases from
primary laryngeal cancer and a second primary lung
cancer were: (i) a period /5 years for the develop-
ment of a lung lesion, in the presence of a squamous
cell carcinoma; and (ii) different clinical and histo-
pathological features.
To test the differences in our population we used
Fisher’s test. Considering the day of the initial surgery
as the first day of observation, the disease-free and
overall survival curves were calculated according to
the Kaplan/Meier method (25).
pB/0.05 was considered statistically significant.
Statistical analysis was performed using the Stata
(Stata Corporation, College Station, TX) and Stat-
Xact (Cytel, Cambridge, MA) programs.
RESULTS
Of the 749 N0 patients, 245 had an elective func-
tional neck dissection and 504 were subjected to close
and regular follow-up. Of the 245 ED patients, 43
(17.5%) had clinically negative neck lymph nodes,
although at the histopathological examination of neck
specimens they showed histologically positive nodes
(N0/), while the remaining 202 patients (82.5%) were
histologically classified as having negative cervical
lymph nodes (N0/). Of the 43 N0/ patients, 21
(48.8%) underwent a unilateral elective functional
neck dissection, 13 (30.3%) a bilateral functional
neck dissection, 8 (18.6%) a unilateral radical neck dis-
section and 1 (2.3%) a radical neck dissection asso-
ciated with a contralateral functional neck dissection.
Of the 504 WS patients, 421 (83%) did not
experience neck disease during follow-up, while the
remaining 83 (17%) had neck failure with the devel-
opment of cervical metastases and were subsequently
submitted to a therapeutic radical neck dissection. The
median time to neck failure was 16 months (range 3/
31 months).
Postoperative radiotherapy was performed to the
neck in 5/43 (11.6%) ED patients who proved to be
N0/ after histopathological examination and in 17/83
(20.5%) WS patients with neck failure. Doses ranged
from 5000 to 6600 cGy (median 5900 cGy).
Of the ED cases (202 patients) without occult neck
disease, 15 developed lymph node metastases contral-
ateral to the previously treated neck in the absence
of local tumor recurrence. Most of these patients
(12/15; 80%) had supraglottic laryngeal carcinomas
involving or extending up to the midline larynx.
Therefore, it is conceivable that we detected occult
contralateral neck metastases already present at the
time of initial treatment (26). Although several nodal
metastases or micrometastases may be missed
by pathologists during routine histologic examinations
(16), we assume that in such cases the initial elective
unilateral neck treatment, which is unable to detect
cancer cells in cervical lymphatics, did not have any
prognostic impact on the development of contralateral
occult disease. Therefore, these patients were further
excluded from the ED group in which we tried
to analyze only N0 laryngeal cancer patients with-
out occult neck disease and for whom the neck surgery
was unnecessary. Therefore, a total of 187 patients
in the ED N0 group did not experience any neck
failure during follow-up. Furthermore, this group was
divided according to the type of elective neck
procedure as follows: (i) 23 patients who underwent
bilateral neck dissection; and (ii) 164 patients who
underwent unilateral lymphadenectomy. According to
these considerations, we tried to evaluate a possible
prognostic impact of unnecessary lymphadenectomy
performed in this group of 187 patients with clinically
and histologically negative neck in comparison with
the 421 N0 laryngeal cancer patients who were
submitted to a wait-and-see policy and for whom
any neck relapse was documented during follow-up.
Postoperative locoregional complications, including
mainly wound infections, hemorrhages and skin
fistulae, were documented in 35 (18.7%) of the ED
patients and 58 (13.7%) of the N0 WS patients
(p/0.323).
Comparative analysis of local and distant relapse in
the three groups (ED unilateral, ED bilateral, WS) did
not show any statistically significant differences. In
fact, we documented an almost analogous rate of local
failure in the three groups (8%, 13%, and 10%,
respectively) (p/0.633) (Table II). Likewise, we did
not find any statistically significant differences among
the three groups analyzed in terms of distant metas-
Fig. 1. Follow-up chart of the material, showing a compar-
ison of local recurrences and distant metastases in the 187
ED N0/ and 421 WS N0/ patients.
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tases (6.7%, 0% and 7.6%, respectively) (p/0.375)
(Table III). Moreover, there was no correlation
between local recurrence and risk of distant
disease, both overall and for each individual group
(p/0.629).
Actuarial analysis of survival did not show statisti-
cally significant differences between the selected
groups in terms of disease-free or corrected survival
(p/0.490 and 0.375, respectively; log rank test) (Fig.
2). In addition, we performed a statistical analysis of
survival according to tumor stage between ED and
WS patients. Among patients with more advanced
(T3/4) laryngeal cancers, a better prognosis, albeit
statistically insignificant (p/0.11; log rank test), was
documented in the ED group.
DISCUSSION
The optimum management of the N0 neck in the
patient with squamous cell carcinoma of the larynx
and upper aerodigestive tract remains controversial.
Several authors (2/4) have shown a consistent rate of
occult metastasis being present at diagnosis in these
patients. In laryngeal cancer patients this rate varies
according to the site and stage of the primary
laryngeal tumor, being higher in supraglottic and
advanced (T3/4) cancers (3/7), but :/20/30% when
all sites and stages are combined. A policy of elective
neck treatment in these N0 patients will therefore
result in overtreatment in almost 70/80% of cases,
with unnecessary morbidity.
Advocates of observation of the N0 neck have also
cited further reasons for this treatment philosophy,
one of which involves avoiding the removal of a barrier
to the spread of disease and the possible subsequent
deleterious immunologic effect. In fact, within the
complex interaction between tumor and host organ-
ism, draining of lymph nodes plays an important role
in the organization and activation of an immune
response induced by tumor antigens.
Table II. Distribution of local failures in 608 patients according to neck procedures. The values shown represent
numbers of patients, with percentages in parentheses
N0/ ED unilateral N0/ ED bilateral N0 WS Total
Local failure
Yes 13 (8) 3 (13) 42 (10) 58 (10)
No 151 (92) 20 (87) 379 (90) 550 (90)
Total 164 23 421 608
Table III. Distribution of distant metastases in 608 patients according to neck procedures. The values shown
represent numbers of patients, with percentages in parentheses
N0/ ED unilateral N0/ ED bilateral N0 WS Total
Distant metastases
Yes 11 (6.7) 0 (0) 32 (7.6) 43 (7)
No 153 (93) 23 (100) 389 (92.5) 565 (93)
Total 164 23 421 608
Fig. 2. (A) Disease-free and (B) overall survival curves for the ED and WS patients.
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In the past, several histomorphologic and, more
recently, functional studies on immune cells from
draining lymph nodes from laryngeal cancer patients
with and without metastases have confirmed that an
active immunologic response in regional lymph nodes
takes place with possible prognostic significance (14/
18). Interestingly, some authors (27/29) demonstrated
that, in metastatic lymph nodes, cancer cells seem to
activate specific and non-specific immunosuppressive
mechanism(s) when compared to unaffected cervical
nodes from head and neck cancer patients. Moreover,
we recently reported (19) that enlarged benign hyper-
plastic (false-positive) lymph nodes showing sinus
histiocytosis were associated with better survival in
patients with advanced laryngeal cancer when com-
pared to those with analogous cancer but without
clinical signs of lymph node enlargement electively
treated to the neck. These studies suggest that the
lymph nodes of the first defense row in the jugular
chain are involved in an active immunological process
in laryngeal cancer patients but that their colonization
from neoplastic cells might be associated with im-
paired immune function (14, 27/29). Therefore, while
it is possible to postulate that the surgical excision of
draining lymph nodes in cancer patients might help
the host immune system in the presence of nodal
metastases, it would also seem that it would weaken
activation of the host’s defense mechanisms in the
absence of tumor spread, by removing structures
responsible for tumor antigen processing as well as
immune cells. According to this hypothesis, this
unnecessary and hypothetically deleterious elective
neck treatment may be responsible for acute and late
effects. The early effects may be correlated with an
increase in locoregional postoperative complications,
such as wound infection with delayed wound healing.
However, it is difficult to demonstrate this because of
the higher morbidity for patients undergoing neck
dissection (due to increased operation time, related
surgical stress and longer hospital stays) in compar-
ison to those who were only treated for primary
laryngeal cancer. Nonetheless, in our series we did
not document any statistically significantly higher risk
of postoperative complications in the ED group when
compared with the WS patients who underwent
laryngeal surgery only.
The late effects involve possible differences in terms
of disease control and survival among patients elec-
tively overtreated in the neck and those who were
simply observed because of host immunosuppression.
Obviously, a well-planned prospective randomized
trial could satisfactorily answer this question. How-
ever, the number of patients needed in order to yield
statistically significant data is difficult to enroll,
particularly by a single institution. In this study we
retrospectively analyzed our own experience with 749
N0 laryngeal cancer patients, some of whom were
overtreated electively (N0) and most of whom were
being treated using a wait-and-see policy. We system-
atically excluded any patient who was submitted to
radiation treatment on the neck, as it would not have
been possible to detect the development of occult
cervical node metastases in these patients.
Although prophylactic radiation treatment and
elective prophylactic neck dissection are equivalent in
controlling subclinical neck disease (30/33), we prefer
the latter, as the current functional neck dissections
and furthermore the selective neck dissections (34)
have resulted in reduced local morbidity, lower med-
ical cost and shorter hospitalization compared to
complementary radiation treatment. In addition to
this we are well aware of the local damage resulting
from radiation therapy both locally (mucositis, xer-
ostomia) and subsequently (endarteritis, radionecrosis,
thyroid injury, radio-induced cancers). Furthermore,
some authors (35) are still debating whether radiation
therapy may have detrimental systemic effects, such as
suppression of both the humoral and cellular arms of
the immune system.
In conclusion, the results of this study offer evidence
that unilateral or bilateral prophylactic neck dissec-
tion, when performed in patients without histologi-
cally proven neck disease, i.e. elective overtreatment,
does not affect the prognosis of laryngeal cancer
patients. In fact, besides neck control of the disease
in patients given elective neck treatment or managed
using a wait-and-see policy (an issue that was not
addressed in this paper), we saw no differences in the
risk of local and distant failure or in the outcome of
the two analyzed groups. This contradicts one of the
assumptions put forward by the proponents of neck
observations and suggests that elective, possible selec-
tive (34) neck dissection is capable of accurately
identifying laryngeal cancer patients with occult neck
metastases at a low N stage with minimal morbidity
and without detrimental prognostic effects in the
overtreated patients (N0).
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